{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-032626","form_type":"8-K","ticker":"CVRX","cik":"0001235912","company_name":"CVRx, Inc.","filed_at":"2025-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.756270+00:00","generated_at":"2026-05-23T19:27:10.183284+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CVRx preliminary Q1 revenue $12.3M (+15% YoY) but below expectations; cites seasonality, new rep ramp","bullets":["Preliminary Q1 2025 revenue ~$12.3M, up 15% YoY from $10.8M.","U.S. revenue ~$11.2M; European revenue ~$1.1M.","Active U.S. implant centers 227 (up from 223 at year-end); sales territories reduced to 45.","Cash and equivalents $102.7M; issued 543,462 shares for $9.5M under ATM in Q1.","CEO noted revenue fell short due to new sales reps developing and Q1 seasonality; full results due May 8."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-032626","json":"https://secwatch.observer/filing/0001104659-25-032626.json","markdown":"https://secwatch.observer/filing/0001104659-25-032626.md","text":"https://secwatch.observer/filing/0001104659-25-032626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1235912/000110465925032626/0001104659-25-032626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1235912/000110465925032626/tm2511651d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T19:27:10.183284+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}